Ohki Healthcare Holdings Co Ltd

Chart & Performance

D1W1MN

P/E

5.06

P/S

0.03

EPS

162.01

Div Yield, %

3.02%

Shrs. gr., 5y

-0.31%

Rev. gr., 5y

5.30%

Revenues

334.66b

+9.92%

Net income

2.21b

+1.28%

CFO

7.55b

+7,762.50%

Dividend

Mar 28, 20250 JPY/sh

Profile

Ohki Healthcare Holdings Co.,Ltd. distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities. The company imports, exports, and sells pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and deleterious substances, drugs, reagents, measuring instruments, optical instruments, electrical products, communication equipment, veterinary drugs, veterinary medical equipment, pet supplies, feed, feed additives, textile products, sanitary products, beauty and health equipment, sports equipment, leisure goods, nursing goods, nursing convenience goods, toys, stationery, homes supplies, daily necessities, groceries, food additives, alcoholic beverages, rice grains, salt, and cigarettes. It also provides chemicals, fertilizers, pesticides, gardening supplies, and agricultural supplies, as well as engages in the warehousing, information processing systems, distribution system equipment, and software development activities. In addition, the company engages in the pharmacy/drug store management and dispensing service, and nursing service businesses; manufacture and sale of pharmaceuticals, quasi-drugs, cosmetics, health foods, killing agents, medical and sanitary products, soft drinks, medical skin care, health food, and miscellaneous goods. Further, it is involved in the manufacture and wholesale of environmental conservation products; and wholesale of food and contact products, cosmetics, and miscellaneous goods, as well as license application agency business. The company was founded in 1658 and is headquartered in Tokyo, Japan.

URL

http://www.ohki-net.co.jp/

IPO date

Oct 01, 2015

Employees

576

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	334,661,000 9.92%	304,445,000 9.45%	278,162,000 2.67%
Cost of revenue	332,708,000	295,764,000	271,030,000
Unusual Expense (Income)
NOPBT	1,953,000	8,681,000	7,132,000
NOPBT Margin	0.58%	2.85%	2.56%
Operating Taxes	1,278,000	998,000	605,000
Tax Rate	65.44%	11.50%	8.48%
NOPAT	675,000	7,683,000	6,527,000
Net income	2,210,000 1.28%	2,182,000 124.49%	972,000 -64.65%
Dividends	(304,000)	(292,000)	(274,000)
Dividend yield	2.23%	2.61%	2.77%
Proceeds from repurchase of equity	(150,000)
BB yield	1.10%
Debt
Debt current	5,421,000	6,617,000	7,180,000
Long-term debt	1,532,000	1,853,000	313,000
Deferred revenue	(4,000)	1,140,000	1,146,000
Other long-term liabilities	1,267,000	180,000	186,000
Net debt	(11,958,000)	(2,582,000)	(2,722,000)
Cash flow
Cash from operating activities	7,548,000	96,000	1,309,000
CAPEX	(277,000)	(319,000)	(144,000)
Cash from investing activities	(496,000)	(291,000)	68,000
Cash from financing activities	(1,996,000)	681,000	(1,403,000)
FCF	4,079,000	6,558,000	6,918,000
Balance
Cash	8,308,000	3,240,000	2,774,000
Long term investments	10,603,000	7,812,000	7,441,000
Excess cash	2,177,950
Stockholders' equity	26,872,000	23,094,000	20,914,000
Invested Capital	33,935,050	33,389,000	30,543,000
ROIC	2.01%	24.03%	21.17%
ROCE	5.19%	25.44%	22.89%
EV
Common stock shares outstanding	13,775	13,792	13,792
Price	990.00 21.92%	812.00 13.25%	717.00 -42.59%
Market cap	13,637,725 21.78%	11,198,718 13.25%	9,888,544 -42.59%
EV	1,740,725	8,762,718	7,311,544
EBITDA	2,330,000	9,056,000	7,513,000
EV/EBITDA	0.75	0.97	0.97
Interest	35,000	33,000	36,000
Interest/NOPBT	1.79%	0.38%	0.50%